Predictive Health Intelligence
@predictivehealth.bsky.social
Ending the late diagnosis of liver disease.
A great morning yesterday at Nursing Live UK, where Dr Katie Denver shared how hepatoSIGHT® helps NHS teams spot liver disease risk earlier using existing blood test data.
Thanks to everyone who joined the discussion on early diagnosis and population health.
#NursingLive2025 #LiverHealth
Thanks to everyone who joined the discussion on early diagnosis and population health.
#NursingLive2025 #LiverHealth
November 6, 2025 at 5:45 PM
A great morning yesterday at Nursing Live UK, where Dr Katie Denver shared how hepatoSIGHT® helps NHS teams spot liver disease risk earlier using existing blood test data.
Thanks to everyone who joined the discussion on early diagnosis and population health.
#NursingLive2025 #LiverHealth
Thanks to everyone who joined the discussion on early diagnosis and population health.
#NursingLive2025 #LiverHealth
Dr Rebecca Cooper MP led a Westminster Hall debate on obesity and fatty liver disease, calling for early detection and treatment across England.
Proud that hepatoSIGHT® was highlighted as proof that clinical and digital teams can unite for patients.
#LiverDisease #NHS #MASLD
Proud that hepatoSIGHT® was highlighted as proof that clinical and digital teams can unite for patients.
#LiverDisease #NHS #MASLD
October 30, 2025 at 10:20 AM
Dr Rebecca Cooper MP led a Westminster Hall debate on obesity and fatty liver disease, calling for early detection and treatment across England.
Proud that hepatoSIGHT® was highlighted as proof that clinical and digital teams can unite for patients.
#LiverDisease #NHS #MASLD
Proud that hepatoSIGHT® was highlighted as proof that clinical and digital teams can unite for patients.
#LiverDisease #NHS #MASLD
Dr Katie Denver will be speaking at #NursingLive next month, sharing how hepatoSIGHT™ helps spot patients at risk of #liverdisease earlier using historic blood test results.
Enabling early identification and research in liver disease
10:00–10:45, Wed 5 Nov
Cardiometabolic zone, NEC
Enabling early identification and research in liver disease
10:00–10:45, Wed 5 Nov
Cardiometabolic zone, NEC
October 22, 2025 at 8:42 AM
Dr Katie Denver will be speaking at #NursingLive next month, sharing how hepatoSIGHT™ helps spot patients at risk of #liverdisease earlier using historic blood test results.
Enabling early identification and research in liver disease
10:00–10:45, Wed 5 Nov
Cardiometabolic zone, NEC
Enabling early identification and research in liver disease
10:00–10:45, Wed 5 Nov
Cardiometabolic zone, NEC
How can data help anticipate population needs?
Most #liverdisease is found late, when symptoms appear and the window for intervention is closing.
The #NHS already holds data that can predict risk. Case-finding helps clinicians identify patients sooner and enable earlier care.
👉 lnkd.in/eSMDDMPu
Most #liverdisease is found late, when symptoms appear and the window for intervention is closing.
The #NHS already holds data that can predict risk. Case-finding helps clinicians identify patients sooner and enable earlier care.
👉 lnkd.in/eSMDDMPu
October 15, 2025 at 10:29 AM
How can data help anticipate population needs?
Most #liverdisease is found late, when symptoms appear and the window for intervention is closing.
The #NHS already holds data that can predict risk. Case-finding helps clinicians identify patients sooner and enable earlier care.
👉 lnkd.in/eSMDDMPu
Most #liverdisease is found late, when symptoms appear and the window for intervention is closing.
The #NHS already holds data that can predict risk. Case-finding helps clinicians identify patients sooner and enable earlier care.
👉 lnkd.in/eSMDDMPu
Our collaborators at Somerset NHS FT & University Hospitals Bristol and Weston NHS FT will be presenting new data at #TheLiverMeeting #TLM25.
Exploring placebo response in #GLP-1 metabolic #liverdisease trials, crucial in understanding how trial results translate to the real world.
📍 Poster #4031
Exploring placebo response in #GLP-1 metabolic #liverdisease trials, crucial in understanding how trial results translate to the real world.
📍 Poster #4031
October 7, 2025 at 1:35 PM
Our collaborators at Somerset NHS FT & University Hospitals Bristol and Weston NHS FT will be presenting new data at #TheLiverMeeting #TLM25.
Exploring placebo response in #GLP-1 metabolic #liverdisease trials, crucial in understanding how trial results translate to the real world.
📍 Poster #4031
Exploring placebo response in #GLP-1 metabolic #liverdisease trials, crucial in understanding how trial results translate to the real world.
📍 Poster #4031
October is #LiverCancerAwarenessMonth.
DYK: In the 🇬🇧 #liver #cancer has surged with over 6k new cases annually?
Or that globally, the # of new cases will almost double by 2050?
We are working hard to change this.
Find out more: lnkd.in/ejqpUiZF
@britishlivertrust.bsky.social #OctoberIs4Livers
DYK: In the 🇬🇧 #liver #cancer has surged with over 6k new cases annually?
Or that globally, the # of new cases will almost double by 2050?
We are working hard to change this.
Find out more: lnkd.in/ejqpUiZF
@britishlivertrust.bsky.social #OctoberIs4Livers
October 1, 2025 at 9:57 AM
October is #LiverCancerAwarenessMonth.
DYK: In the 🇬🇧 #liver #cancer has surged with over 6k new cases annually?
Or that globally, the # of new cases will almost double by 2050?
We are working hard to change this.
Find out more: lnkd.in/ejqpUiZF
@britishlivertrust.bsky.social #OctoberIs4Livers
DYK: In the 🇬🇧 #liver #cancer has surged with over 6k new cases annually?
Or that globally, the # of new cases will almost double by 2050?
We are working hard to change this.
Find out more: lnkd.in/ejqpUiZF
@britishlivertrust.bsky.social #OctoberIs4Livers
The people affected by health innovations should have a voice in shaping them. That's why our PPRG sits at the heart of everything we do.
Hear from our members about why they got involved and the value they bring.
Interested in joining? Learn more: predictivehealthintelligence.co.uk/contact/
Hear from our members about why they got involved and the value they bring.
Interested in joining? Learn more: predictivehealthintelligence.co.uk/contact/
September 23, 2025 at 8:48 AM
The people affected by health innovations should have a voice in shaping them. That's why our PPRG sits at the heart of everything we do.
Hear from our members about why they got involved and the value they bring.
Interested in joining? Learn more: predictivehealthintelligence.co.uk/contact/
Hear from our members about why they got involved and the value they bring.
Interested in joining? Learn more: predictivehealthintelligence.co.uk/contact/
We're heading to #BASL2025!
Book a meeting with us to learn how we're ending the late diagnosis of #liverdisease: lnkd.in/ekvVUqP3
📍BASL 2025
🗺️ Belfast ICC
🗓️ 8 -10 October
#PublicHealth #CaseFinding #EarlyDiagnosis
Book a meeting with us to learn how we're ending the late diagnosis of #liverdisease: lnkd.in/ekvVUqP3
📍BASL 2025
🗺️ Belfast ICC
🗓️ 8 -10 October
#PublicHealth #CaseFinding #EarlyDiagnosis
September 18, 2025 at 8:54 AM
We're heading to #BASL2025!
Book a meeting with us to learn how we're ending the late diagnosis of #liverdisease: lnkd.in/ekvVUqP3
📍BASL 2025
🗺️ Belfast ICC
🗓️ 8 -10 October
#PublicHealth #CaseFinding #EarlyDiagnosis
Book a meeting with us to learn how we're ending the late diagnosis of #liverdisease: lnkd.in/ekvVUqP3
📍BASL 2025
🗺️ Belfast ICC
🗓️ 8 -10 October
#PublicHealth #CaseFinding #EarlyDiagnosis
Too many liver trials recruit from the same clinics, excluding those most affected. Our latest article looks at how broader eligibility, non-invasive tests, outreach, + case-finding can make research more representative.
www.linkedin.com/pulse/proble...
#LiverDisease #ClinicalTrials #HealthEquity
www.linkedin.com/pulse/proble...
#LiverDisease #ClinicalTrials #HealthEquity
The problem with liver trial bias, and how smart design can improve access.
Every new therapy relies on years of painstaking research, but what if that research overlooks the very people most in need? The problem: a mismatch between trials and reality Ethnic minorities, peopl...
www.linkedin.com
September 16, 2025 at 10:15 AM
Too many liver trials recruit from the same clinics, excluding those most affected. Our latest article looks at how broader eligibility, non-invasive tests, outreach, + case-finding can make research more representative.
www.linkedin.com/pulse/proble...
#LiverDisease #ClinicalTrials #HealthEquity
www.linkedin.com/pulse/proble...
#LiverDisease #ClinicalTrials #HealthEquity
Today we're launching “In practice with Dr Denver,” our new clinical insights series.
Read our first article about Alpha-1 Antitrypsin Deficiency, care gaps, and case-finding: www.linkedin.com/pulse/practi...
#LiverDisease #MedTech #A1ATD
Read our first article about Alpha-1 Antitrypsin Deficiency, care gaps, and case-finding: www.linkedin.com/pulse/practi...
#LiverDisease #MedTech #A1ATD
In Practice with Dr. Denver: How can case-finding help close care gaps for people with Alpha-1 Antitrypsin Deficiency (A1ATD)?
Care gaps are present across the care pathway for A1ATD-related liver disease; it is significantly underdiagnosed, suffers from a lack of awareness, and currently there are no approved pharmacological...
www.linkedin.com
September 9, 2025 at 7:51 AM
Today we're launching “In practice with Dr Denver,” our new clinical insights series.
Read our first article about Alpha-1 Antitrypsin Deficiency, care gaps, and case-finding: www.linkedin.com/pulse/practi...
#LiverDisease #MedTech #A1ATD
Read our first article about Alpha-1 Antitrypsin Deficiency, care gaps, and case-finding: www.linkedin.com/pulse/practi...
#LiverDisease #MedTech #A1ATD
Around 80% of liver disease cases in the UK are diagnosed too late, increasing pressure on secondary care.
Innovation is key to earlier diagnosis and efficient use of NHS resources.
See how we're making an impact: predictivehealthintelligence.co.uk/professional...
#LiverDisease #EarlyDiagnosis
Innovation is key to earlier diagnosis and efficient use of NHS resources.
See how we're making an impact: predictivehealthintelligence.co.uk/professional...
#LiverDisease #EarlyDiagnosis
August 21, 2025 at 8:31 AM
Around 80% of liver disease cases in the UK are diagnosed too late, increasing pressure on secondary care.
Innovation is key to earlier diagnosis and efficient use of NHS resources.
See how we're making an impact: predictivehealthintelligence.co.uk/professional...
#LiverDisease #EarlyDiagnosis
Innovation is key to earlier diagnosis and efficient use of NHS resources.
See how we're making an impact: predictivehealthintelligence.co.uk/professional...
#LiverDisease #EarlyDiagnosis
Addressing #SDoH is critical for equitable clinical trial access.
hepatoSIGHT™ helps identify underserved communities using deprivation indices, supporting inclusive recruitment.
Let’s ensure trials reflect the populations they aim to serve.
#LiverDisease #ClinicalTrials #HealthEquity
hepatoSIGHT™ helps identify underserved communities using deprivation indices, supporting inclusive recruitment.
Let’s ensure trials reflect the populations they aim to serve.
#LiverDisease #ClinicalTrials #HealthEquity
August 19, 2025 at 8:32 AM
Addressing #SDoH is critical for equitable clinical trial access.
hepatoSIGHT™ helps identify underserved communities using deprivation indices, supporting inclusive recruitment.
Let’s ensure trials reflect the populations they aim to serve.
#LiverDisease #ClinicalTrials #HealthEquity
hepatoSIGHT™ helps identify underserved communities using deprivation indices, supporting inclusive recruitment.
Let’s ensure trials reflect the populations they aim to serve.
#LiverDisease #ClinicalTrials #HealthEquity
Care in the best place means spotting disease before it becomes a crisis.
Liver disease is often diagnosed in A&E, damage is advanced, options limited, + outcomes poor.
The challenge isn’t just treatment, it's timing.
➡️ We need to shift care upstream.
#LiverDisease #LiverCancer #PublicHealth
Liver disease is often diagnosed in A&E, damage is advanced, options limited, + outcomes poor.
The challenge isn’t just treatment, it's timing.
➡️ We need to shift care upstream.
#LiverDisease #LiverCancer #PublicHealth
August 12, 2025 at 11:05 AM
Care in the best place means spotting disease before it becomes a crisis.
Liver disease is often diagnosed in A&E, damage is advanced, options limited, + outcomes poor.
The challenge isn’t just treatment, it's timing.
➡️ We need to shift care upstream.
#LiverDisease #LiverCancer #PublicHealth
Liver disease is often diagnosed in A&E, damage is advanced, options limited, + outcomes poor.
The challenge isn’t just treatment, it's timing.
➡️ We need to shift care upstream.
#LiverDisease #LiverCancer #PublicHealth
@timjobson.bsky.social joined the Surfing the MASH Tsunami podcast with Roger Green & Louise Campbell to discuss hepatoSIGHT™ and how it’s speeding better treatments to patients. A must-listen for #ClinicalTrials & #LiverDisease #LiverTwitter
podcasts.apple.com/gb/podcast/6...
podcasts.apple.com/gb/podcast/6...
6.10.3 - Expert: Tim Jobson on Using Basic Data and Analytics to Identify At-Risk Patients
Podcast Episode · Surfing the MASH Tsunami · S6, E10 Bonus · 37m
podcasts.apple.com
August 11, 2025 at 10:19 AM
@timjobson.bsky.social joined the Surfing the MASH Tsunami podcast with Roger Green & Louise Campbell to discuss hepatoSIGHT™ and how it’s speeding better treatments to patients. A must-listen for #ClinicalTrials & #LiverDisease #LiverTwitter
podcasts.apple.com/gb/podcast/6...
podcasts.apple.com/gb/podcast/6...
#LiverDisease is often diagnosed too late. But it doesn’t have to be.
hepatoSIGHT™ helps #NHS teams find undiagnosed cases using historic blood test data, securely and at scale.
In Somerset alone, over 700 people have already been identified. Get in touch to learn more.
hepatoSIGHT™ helps #NHS teams find undiagnosed cases using historic blood test data, securely and at scale.
In Somerset alone, over 700 people have already been identified. Get in touch to learn more.
August 8, 2025 at 10:41 AM
#LiverDisease is often diagnosed too late. But it doesn’t have to be.
hepatoSIGHT™ helps #NHS teams find undiagnosed cases using historic blood test data, securely and at scale.
In Somerset alone, over 700 people have already been identified. Get in touch to learn more.
hepatoSIGHT™ helps #NHS teams find undiagnosed cases using historic blood test data, securely and at scale.
In Somerset alone, over 700 people have already been identified. Get in touch to learn more.
Study design often breaks at recruitment.
hepatoSIGHT™ helps sponsors use real data by geography, demographics, and historic labs to model eligibility before trials start.
Get in touch to see how.
#LiverDisease #MASH #RWE #ClinicalTrials
hepatoSIGHT™ helps sponsors use real data by geography, demographics, and historic labs to model eligibility before trials start.
Get in touch to see how.
#LiverDisease #MASH #RWE #ClinicalTrials
July 31, 2025 at 7:25 AM
Study design often breaks at recruitment.
hepatoSIGHT™ helps sponsors use real data by geography, demographics, and historic labs to model eligibility before trials start.
Get in touch to see how.
#LiverDisease #MASH #RWE #ClinicalTrials
hepatoSIGHT™ helps sponsors use real data by geography, demographics, and historic labs to model eligibility before trials start.
Get in touch to see how.
#LiverDisease #MASH #RWE #ClinicalTrials
For a decade, sponsors have been promised transformation in #MASH recruitment yet timelines still lag.
Research shows our approach with hepatoSIGHT™ can identify 1,819 eligible patients per trial in population of 10 mil.
10% enrolment rate = 70 conventional sites.
🔗 gut.bmj.com/content/73/S...
Research shows our approach with hepatoSIGHT™ can identify 1,819 eligible patients per trial in population of 10 mil.
10% enrolment rate = 70 conventional sites.
🔗 gut.bmj.com/content/73/S...
July 25, 2025 at 8:27 AM
For a decade, sponsors have been promised transformation in #MASH recruitment yet timelines still lag.
Research shows our approach with hepatoSIGHT™ can identify 1,819 eligible patients per trial in population of 10 mil.
10% enrolment rate = 70 conventional sites.
🔗 gut.bmj.com/content/73/S...
Research shows our approach with hepatoSIGHT™ can identify 1,819 eligible patients per trial in population of 10 mil.
10% enrolment rate = 70 conventional sites.
🔗 gut.bmj.com/content/73/S...
Premature liver deaths in England are up 42% since 2001¹. 1/2 are only diagnosed in A&E². Up to 90% of cases are preventable³.
Existing lab data + tools like hepatoSIGHT™ mean NHS Trusts can identify risk earlier. Preventative, data-driven healthcare in action.
Sources 👇
Existing lab data + tools like hepatoSIGHT™ mean NHS Trusts can identify risk earlier. Preventative, data-driven healthcare in action.
Sources 👇
July 22, 2025 at 11:47 AM
Premature liver deaths in England are up 42% since 2001¹. 1/2 are only diagnosed in A&E². Up to 90% of cases are preventable³.
Existing lab data + tools like hepatoSIGHT™ mean NHS Trusts can identify risk earlier. Preventative, data-driven healthcare in action.
Sources 👇
Existing lab data + tools like hepatoSIGHT™ mean NHS Trusts can identify risk earlier. Preventative, data-driven healthcare in action.
Sources 👇
Great to join Lyngford Park GP Surgery’s open day yesterday.
13 people viewed our draft hepatoSIGHT™ explainer, feedback was thoughtful, positive & helped us sharpen how we talk about liver disease & data safety.
Big thanks to Jeanette Keech & the team!
#PPI #PatientEngagement
13 people viewed our draft hepatoSIGHT™ explainer, feedback was thoughtful, positive & helped us sharpen how we talk about liver disease & data safety.
Big thanks to Jeanette Keech & the team!
#PPI #PatientEngagement
July 17, 2025 at 11:53 AM
Great to join Lyngford Park GP Surgery’s open day yesterday.
13 people viewed our draft hepatoSIGHT™ explainer, feedback was thoughtful, positive & helped us sharpen how we talk about liver disease & data safety.
Big thanks to Jeanette Keech & the team!
#PPI #PatientEngagement
13 people viewed our draft hepatoSIGHT™ explainer, feedback was thoughtful, positive & helped us sharpen how we talk about liver disease & data safety.
Big thanks to Jeanette Keech & the team!
#PPI #PatientEngagement
CLDI turns "how bad, for how long?" into a precise number.
hepatoSIGHT™ helps clinicians quantify #liverdisease over decades, predicting advanced disease proactively. A new way to see liver health as a trajectory, not snapshots.
Read more: gut.bmj.com/content/71/S...
#NHS #PublicHealth
hepatoSIGHT™ helps clinicians quantify #liverdisease over decades, predicting advanced disease proactively. A new way to see liver health as a trajectory, not snapshots.
Read more: gut.bmj.com/content/71/S...
#NHS #PublicHealth
O06 A cumulative liver damage index (CLDI) identifies patients at risk of significant liver disease
Background Late diagnosis of liver disease is a major factor in poor outcomes, with many missed opportunities for effective interventions. Identifying at risk patients is hampered by the high prevalen...
gut.bmj.com
July 16, 2025 at 6:20 AM
CLDI turns "how bad, for how long?" into a precise number.
hepatoSIGHT™ helps clinicians quantify #liverdisease over decades, predicting advanced disease proactively. A new way to see liver health as a trajectory, not snapshots.
Read more: gut.bmj.com/content/71/S...
#NHS #PublicHealth
hepatoSIGHT™ helps clinicians quantify #liverdisease over decades, predicting advanced disease proactively. A new way to see liver health as a trajectory, not snapshots.
Read more: gut.bmj.com/content/71/S...
#NHS #PublicHealth
Often, when patients with #liverdisease reach clinic, their bloods paint a familiar story. Clues that were there all along, just never seen together in time.
hepatoSIGHT™ changes that.
It's about extending clinical instinct with real-world data. No new playbook, just the ability to get ahead.
hepatoSIGHT™ changes that.
It's about extending clinical instinct with real-world data. No new playbook, just the ability to get ahead.
July 3, 2025 at 12:03 PM
Often, when patients with #liverdisease reach clinic, their bloods paint a familiar story. Clues that were there all along, just never seen together in time.
hepatoSIGHT™ changes that.
It's about extending clinical instinct with real-world data. No new playbook, just the ability to get ahead.
hepatoSIGHT™ changes that.
It's about extending clinical instinct with real-world data. No new playbook, just the ability to get ahead.
80% of #liverdisease trials fail to reach recruitment targets.
#ClinicalTrials are good for patients, good for health systems, and good for the country. That's why we're pleased to be featured on the Enterprise Europe Network for our work accelerating research:
een.ec.europa.eu/partnering-o...
#ClinicalTrials are good for patients, good for health systems, and good for the country. That's why we're pleased to be featured on the Enterprise Europe Network for our work accelerating research:
een.ec.europa.eu/partnering-o...
June 25, 2025 at 12:48 PM
80% of #liverdisease trials fail to reach recruitment targets.
#ClinicalTrials are good for patients, good for health systems, and good for the country. That's why we're pleased to be featured on the Enterprise Europe Network for our work accelerating research:
een.ec.europa.eu/partnering-o...
#ClinicalTrials are good for patients, good for health systems, and good for the country. That's why we're pleased to be featured on the Enterprise Europe Network for our work accelerating research:
een.ec.europa.eu/partnering-o...
“Some country will lead the charge in life sciences—why shouldn’t it be Britain?” – Wes Streeting MP
What's in the 10-Year Clinical Trial Plan:
👉 Set-up times: 250 → 150 days
👉 Trusts must report progress
👉 Funding tied to performance
Read more: www.gov.uk/government/n...
#ClinicalTrials #NHS
What's in the 10-Year Clinical Trial Plan:
👉 Set-up times: 250 → 150 days
👉 Trusts must report progress
👉 Funding tied to performance
Read more: www.gov.uk/government/n...
#ClinicalTrials #NHS
June 16, 2025 at 4:25 PM
“Some country will lead the charge in life sciences—why shouldn’t it be Britain?” – Wes Streeting MP
What's in the 10-Year Clinical Trial Plan:
👉 Set-up times: 250 → 150 days
👉 Trusts must report progress
👉 Funding tied to performance
Read more: www.gov.uk/government/n...
#ClinicalTrials #NHS
What's in the 10-Year Clinical Trial Plan:
👉 Set-up times: 250 → 150 days
👉 Trusts must report progress
👉 Funding tied to performance
Read more: www.gov.uk/government/n...
#ClinicalTrials #NHS
Exciting News! We're at #NHSConfedExpo 2025!
Find us at Stand A10 to see how hepatoSIGHT™ is helping transform liver disease care across the #NHS.
Let’s talk prevention, integration & impact. June 11–12, Manchester Central. Book a meeting: predictivehealthintelligence.co.uk/contact/
#LiverDisease
Find us at Stand A10 to see how hepatoSIGHT™ is helping transform liver disease care across the #NHS.
Let’s talk prevention, integration & impact. June 11–12, Manchester Central. Book a meeting: predictivehealthintelligence.co.uk/contact/
#LiverDisease
June 9, 2025 at 9:29 AM
Exciting News! We're at #NHSConfedExpo 2025!
Find us at Stand A10 to see how hepatoSIGHT™ is helping transform liver disease care across the #NHS.
Let’s talk prevention, integration & impact. June 11–12, Manchester Central. Book a meeting: predictivehealthintelligence.co.uk/contact/
#LiverDisease
Find us at Stand A10 to see how hepatoSIGHT™ is helping transform liver disease care across the #NHS.
Let’s talk prevention, integration & impact. June 11–12, Manchester Central. Book a meeting: predictivehealthintelligence.co.uk/contact/
#LiverDisease